Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from the Food and Drug Administration

Medication abortion is still possible with just one drug. Here's how it works

A judge's ruling puts access to the abortion drug mifepristone in limbo, pending further court decisions. But there's another drug that is safe and effective at ending early pregnancy.

WEKU

US abortion pill access in doubt after Texas judge suspends approval

Abortion medication mifepristone has been available in the US for more than 20 years

Evening Standard

US access to abortion pill mifepristone in limbo after conflicting judicial rulings

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

France 24

From analysis to the latest developments in health,
read the most diverse news in one place.

Abortion pill ruling: Texas judge orders hold on FDA approval, but another judge contradicts him

ATLANTA — A federal judge in Texas delivered a major blow to reproductive rights advocates Friday, ordering a hold on the Food and Drug Administration approval of mifepristone, an abortion medication used in the United States since 2000.

Los Angeles Times

Unsafe cadmium level detected in seaweed product

The Food and Drug Administration (FDA) has warned people not to consume a certain lot of roasted nori seaweed products due to potential contamination of cadmium.

Bangkok Post

FDA forces unproven premature birth drug Makena off market

The Food and Drug Administration is ordering an unproven drug intended to prevent premature births off the market

The Independent UK

FDA warns public of toxic hair dye

The Food and Drug Administration (FDA) on Tuesday warned consumers that three South Korean hair-dyeing products contain cancer-causing chemicals.

Bangkok Post

Read news from The Economist, FT, and more,
with one subscription

Starbucks recall - 300,000 bottled Frappuccino drinks recalled

We share everything you need to know about the Starbucks recall, as 300,000 drinks are pulled from shelves.

GoodToKnow

The FDA may soon authorize a spring round of COVID-19 boosters for some people

The Food and Drug Administration appears poised to make available the COVID-19 vaccines that target omicron as a second booster for people with weak immune systems and those ages 65 and older.

WEKU

The FDA approves the overdose-reversing drug Narcan for over-the-counter sales

The decision could make the life-saving drug more accessible. Emergent BioSolutions, the drug company that produces Narcan, said it anticipates it will be on store shelves by late summer.

WEKU

Parents warned, kids eating smuggled cannabis cookies

The Food and Drug Administration (FDA) has warned parents to be alert after "many children" in the south were hospitalised after eating smuggled cannabis-infused cookies containing excessive levels of psychoactive tetrahydrocannabinol (THC).

Bangkok Post

Alzheimer’s report hints at a future health crisis bigger than COVID-19

The costs of Alzheimer’s disease – human and financial – are rising sharply in California and nationally, and census projections for America’s rapidly aging population suggest the scope of the disease soon might rival what America saw during the height of the COVID-19 pandemic.

The Orange County Register

COVID-19 Pill Paxlovid Moves Closer to Full FDA Approval

Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from US health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.

Asharq Al-Awsat

Sickle cell patient's success with gene editing raises hopes and questions

A Mississippi woman's life has been transformed by a treatment for sickle cell disease with the gene-editing technique CRISPR. All her symptoms from a disease once thought incurable have disappeared.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Judge weighs FDA approval of abortion drug

WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide.

The Independent UK

Medication abortions are under fire: Here's how they work

Medication abortions became the preferred method for ending pregnancy in the U.S. even before the Supreme Court overturned Roe v. Wade

The Independent UK

Abortion pill hearing made public after transparency concern

A judge is set to hear arguments in a lawsuit that poses a threat to the nationwide availability of medication abortion

Ballotpedia

Democratic attorneys general sue Biden administration over FDA abortion pill regulation

A group of 12 Democratic state attorneys general filed a lawsuit in the United States District Court for the Eastern District of Washington against the Food and Drug Administration (FDA) on Feb. 23, 2023, arguing that the agency’s regulations on the abortion-inducing drug mifepristone violate state sovereignty by limiting the…

Get all your
news in one place.

100’s of premium titles.
One news app.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

1,727 stories

ADF

529 stories

the World Health Organization

the Food and Drug Administration

168 stories

the Alzheimer Association

33 stories

Whole Woman Health

26 stories

Alzheimer Association

18 stories

the Alliance for Hippocratic Medicine

13 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.